Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

By Torp-Pedersen C.   Brendorp B.   Køber L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2695-2704

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Drug Monitoring of Antiarrhythmic Drugs

By Jürgens Gesche  

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 647-663

Adis International

Access to resources Recommend Favorite

Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action

By Kushida S.   Ogura T.   Komuro I.   Nakaya H.  

European Journal of Pharmacology, Vol. 457, Iss. 1, 2002-12 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

Study of Physicochemical Properties and Development of Pharmaceutial Analysis of the New Antiarrhythmic Class III Drug Cardiocyclide

By Grushevskaya L. N.   Avdyunina N. I.   Stepanenko O. B.   Pyatin B. M.   Prokof'eva V. I.   Lezina V. P.  

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 12, 2003-12 ,pp. : 677-680

Springer Publishing Company

Access to resources Recommend Favorite

Exposure to Potentially Inappropriate Drugs and Drug-Drug Interactions in Elderly Nursing Home Residents in Helsinki, Finland: A Cross-Sectional Study

By Hosia-Randell Helka M.V.   Muurinen Seija M.   Pitkälä Kaisu H.  

Drugs & Aging, Vol. 25, Iss. 8, 2008-01 ,pp. : 683-692

Adis International

Access to resources Recommend Favorite